Partners Capital Investment Group, LLP Allogene Therapeutics, Inc. Transaction History
Partners Capital Investment Group, LLP
- $3.34 Billion
- Q4 2024
A detailed history of Partners Capital Investment Group, LLP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 93,248 shares of ALLO stock, worth $140,804. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,248
Previous 254,845
63.41%
Holding current value
$140,804
Previous $713,000
72.23%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ALLO
# of Institutions
166Shares Held
134MCall Options Held
59.4KPut Options Held
113K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$28.3 Million1.25% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$24.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.01MShares$10.6 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$10.4 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $217M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...